Estimating the population health and economic impacts of introducing a pneumococcal conjugate vaccine in Malaysia- an economic evaluation

Estimating the population health and economic impacts of introducing a pneumococcal conjugate vaccine in Malaysia- an economic evaluation

Pneumococcal disease is a potentially fatal bacterial infection that is vaccine-preventable. Malaysia has yet to adopt a pneumococcal conjugate vaccine (PCV) into its national immunization program (NIP). In 2016, pneumonia was the 3rd leading cause of death in children under five in Malaysia, accoun...

Full description

Bibliographic Details
Main Authors: Asrul Akmal Shafie, Norazah Ahmad, Jerusha Naidoo, Chee Yoong Foo, Callix Wong, Sarah Pugh, Kah Kee Tan
Format: Article
Language:English
Published: Taylor & Francis Group 2020-07-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
cost-effectiveness
decision analytic model
pneumococcal disease
pneumococcal conjugate vaccine
malaysia
Online Access:http://dx.doi.org/10.1080/21645515.2019.1701911

Internet

http://dx.doi.org/10.1080/21645515.2019.1701911

Similar Items